SEC Form 4 · accession 0001209191-16-103390

ReShape Lifesciences Inc. · RSLS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Mark B Knudson

Director

Period of report

Feb 25, 2016

Accepted (ET)

Feb 29, 2016 · 4:30 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001371217

Table I — non-derivative securities

Security	Date	Code	Shares	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	holding	—	—	—	93	I	Spouse Revocable Trust
Common Stock^F1	holding	—	—	—	215	I	Family Limited Partnership
Common Stock^F1	holding	—	—	—	3,838	I	Revocable Trust 2003
Common Stock^F1	holding	—	—	—	40,867	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Director Option (right to buy)^F5	$1.07	Feb 25, 2016	A	3,333	A	Feb 25, 2016	Feb 25, 2026	Common Stock	3,333	3,333	D
Stock Option (right to buy)^F1,F2	$41.40	holding	—	—	—	—	Apr 20, 2016	Common Stock	451	451	D
Stock Option (right to buy)^F1,F2	$28.50	holding	—	—	—	—	Oct 29, 2017	Common Stock	2,228	2,228	D
Stock Option (right to buy)^F1,F2	$28.50	holding	—	—	—	—	Oct 29, 2017	Common Stock	1,726	1,726	D
Stock Option (right to buy)^F1,F2	$28.50	holding	—	—	—	—	Oct 29, 2017	Common stock	2,942	2,942	D
Stock Option (right to buy)^F1,F2	$28.50	holding	—	—	—	—	Oct 29, 2017	Common Stock	3,364	3,364	D
Stock Option (right to buy)^F1,F2	$56.70	holding	—	—	—	—	Dec 31, 2018	Common Stock	1,388	1,388	D
Warrant (common stock right to buy)^F1,F3,F4	$32.85	holding	—	—	—	—	—	Common Stock	1,666	1,666	D
Stock Option (right to buy)^F1,F2	$38.70	holding	—	—	—	—	Dec 31, 2018	Common Stock	23,333	23,333	D
Stock Option (right to buy)^F1,F2	$40.05	holding	—	—	—	—	Dec 31, 2018	Common Stock	23,333	23,333	D
Stock Option (right to buy)^F1,F2	$28.50	holding	—	—	—	—	Dec 31, 2018	Common Stock	13,333	13,333	D
Stock Option (right to buy)^F1,F2	$50.25	holding	—	—	—	—	Dec 31, 2018	Common Stock	86,148	86,148	D
Stock Option (right to buy)^F1,F2	$19.65	holding	—	—	—	—	Dec 31, 2018	Common Stock	85,248	85,248	D
Stock Option (right to buy)^F1,F2	$16.65	holding	—	—	—	—	Dec 31, 2018	Common Stock	15,000	15,000	D

Explanation of responses

F1On January 6, 2016, EnteroMedics Inc. effected a 1-for-15 reverse stock split of its issued and outstanding shares of common stock, par value $0.01 per share, resulting in a proportional decrease in the total shares of common stock beneficially owned by the reporting person. all previously reported exercise prices, option grants and similar instruments convertible into common stock were proportionally adjusted to reflect the reverse split.
F2Options currently 100% vested.
F3Warrant becomes exercisable 181 days from the date of issuance at close of offering.
F4Warrant expires five years from the date it becomes exercisable.
F5Vests immediately as to 25% on date noted and thereafter in cumulative installments of 1/36th per month.

Remarks

THIS FILING REFLECTS THE POST SPLIT NUMBERS OF ALL SHARES, OPTIONS AND SIMILAR INSTRUMENTS HELD BY THE REPORTING PERSON AS PREVIOUSLY REPORTED. As reported on a Form 8-K filed by the Company on 8/25/2015, in connection with the reporting person's retirement at the end of 2015, all of his unvested options outstanding on that date were fully vested as of his retirement date and the term during which those options could be exercised was extended to 12/31/2018.